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Abstract. Thrombosis of ventricular assist devices (VADs) compromises their performance, 
with associated risks of systemic embolization, stroke, pump stop and possible death. Anti-
thrombotic (AT) drugs, utilized to limit thrombosis, are largely dosed empirically, with limited 
testing of their efficacy.  Further, such testing, if performed, typically examines efficacy under 
static conditions, which is not reflective of actual shear-mediated flow.  Here we adopted our 
previously developed Device Thrombogenicity Emulation methodology to design microfluidic 
platforms able to emulate representative shear stress profiles of mechanical circulatory support 
(MCS) devices. Our long-term goal is to utilize these systems for point-of-care (POC) 
personalized testing of AT efficacy under specific, individual shear profiles.  First, we designed 
different types of microfluidic channels able to replicate sample shear stress patterns observed in 
MCS devices. Second, we explored the flexibility of microfluidic technology in generating 
dynamic shear stress profiles by modulating the geometrical features of the channels. Finally, we 
designed microfluidic channel systems able to emulate the shear stress profiles of two 
commercial VADs. From CFD analyses, the VAD-emulating microfluidic systems were able to 
replicate the main characteristics of the shear stress waveforms of the macroscale VADs (i.e. 
shear stress peaks and duration). Our results establish the basis for development of a lab-on-chip 
POC system able to perform device-specific and patient-specific platelet activation state assays. 
Keywords. Mechanical Circulatory Support, Ventricular Assist Devices, Thrombosis, 
Microfluidics, Computational Fluid Dynamics, Anti-thrombotic therapy. 
Abbreviations.  
AR Aspect Ratio O Obstructive 
CFD Computational Fluid Dynamics PAS Platelet Activation State                            
DTE Device Thrombogenicity Emulator PDF Probability Density Function 
HA5 Heart Assist 5 PDMS Polydimethylsiloxane                    
HMII HeartMate II  POC Point-of-Care 
HSD Hemodynamic Shearing Device SA Stress Accumulation                                                                       
MCS Mechanical Circulatory Support VAD Ventricular Assist Device. 





          Mechanical circulatory support (MCS) devices have emerged as a major advance in the 
management of patients with advanced heart failure (Stewart et al. 2012). Despite their clinical 
success, MCS devices unfortunately are plagued by device-related thrombosis (Mehra et al 
2014), often resulting in reduced function, recurrent heart failure, systemic emboli, possible 
stroke, potential pump stop and even death.  To prevent thrombosis, MCS-implanted patients 
rely on the use of a combination of anti-thrombotic agents (e.g. aspirin, dipyridamole, 
clopidrogel) to limit platelet activation resulting from passage through the device (Eckman and 
Ranjit 2012, Von Ruden et al 2012). Despite the use of these drugs, thrombosis has persisted as a 
clinical problem (Starling et al 2014). A weakness of the present pharmacologic strategy is the 
fact that administered drugs are typically monitored only in the peri-operative period, during 
hospitalization and immediately thereafter. Drug monitoring in the out-of-hospital home 
environment is still not a common practice, with few systems available for routine point-of-care 
or home-based monitoring of platelet function (Mani et al 2014). More often, drug monitoring is 
performed with laboratory-based devices, e.g. light-based aggregometry or PFA-100. These 
assays largely examine biochemical endpoints of platelet activation, studied under static 
conditions or constant shear conditions, and are not reflective of the actual dynamic shear and 
flow that occurs in a given MCS device, particularly as to the shear stress levels and dose to 
which platelets are exposed.  
Shear forces are a major means of activation of platelets, as platelets pass through small 
dimensions and unusual geometries at high speed in MCS systems. Our laboratories have 
characterized many blood-contacting systems, including MCS devices, and have described the 
overall shear stress history and dose as a probability density function (PDF) of a scalar value, 
termed Stress Accumulation (SA), that takes into account the shear stress levels and exposure 
time acting on individual platelets. A PDF is device-specific and can be seen as its 
"thrombogenic footprint", representing a means of calculating the net shear exposure history of a 
large population of platelets passing through the device.  
Device Thrombogenicity Emulation (DTE) as a methodology allows one to subject platelets 
to realistic shear stress profiles obtained from complex computational fluid dynamics (CFD) 
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analyses performed within realistic geometries of cardiac devices (Xenos et al 2010, Alemu et al 
2010). The flow path in the device is modeled and platelets are tracked in order to detect 
individual platelet trajectories that may drive them beyond the activation threshold. For this 
purpose, cumulative stress, i.e. the SA, is calculated along multiple flow trajectories (thousands 
of simulated platelet trajectories) and collapsed into PDFs. Extreme cases of platelet stress 
loading trajectories, termed as “hotspot” or “flight” trajectories, can be extracted from the PDF 
and reproduced in vitro for actual exposure of platelets via a novel lab system - a Hemodynamic 
Shearing Device (HSD) (Nobili et al 2008). The HSD consists of a programmable high-torque 
servo motor-controller system (Baldor Electric Company, AR) that propels the platelet sample in 
a modified cone-Couette viscometer with the capability of exposing platelets to highly-controlled 
dynamic, uniform shear stress waveforms (Xenos et al 2010). The HSD-treated platelet sample is 
then assayed for platelet activation via the Platelet Activation State (PAS) assay (Jesty and 
Bluestein 1999) developed by our group, which measures the rate of  thrombin generation as a 
surrogate validated biomarker. While initially developed to analyze mechanical heart valves 
(Xenos et al 2010, Alemu et al 2010), the DTE methodology has been utilized to evaluate and 
optimize MCS devices, such as ventricular assist devices (VADs) (Girdhar et al 2012). Herein, 
we hypothesized that the individual shear and flow characteristics of a given VAD, i.e. defined 
hotspot trajectories, may be emulated in a microfluidic channel system. As such, creating a 
"Device-Specific" VAD microfluidic facsimile would ultimately allow development of a small, 
point-of-care, lab-on-a chip system that may be utilized readily at the bedside to assess the 
adequacy of anti-thrombotic drug efficacy. We envision a point-of care system made of 
polydimethylsiloxane (PDMS), through standard soft lithography (Whitesides 2006).  
As such, the overall goal of the present study was to investigate the feasibility of designing 
microfluidic emulators capable of replicating MCS fluid dynamics in terms of dynamic shear 
stress history patterns. Here we generate the PDFs of two VADs in actual clinical use. Using 
these PDFs we translate and replicate specific component shear stress peaks into fluid 
microchannel geometries. We then examine the flexibility of this microfluidic approach via 
changing channel design features in order to modulate shear stress curves. Finally, we design two 
different microfluidic platforms to emulate the shear stress history defined by the device specific 
PDFs of two commercial VADs. 
2. METHODS AND MATERIALS 
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          The essence of the present approach is to modulate the geometry of microfluidic channels 
in order to generate shear stress history patterns that replicate MCS device shear patterns. In 
particular, two commercial VADs, the HeartAssist5 (HA5, MicroMed Technology Inc., Houston, 
TX, USA) and HeartMateII (HMII, Thoratec Corportation, Pleasanton, CA, USA) VADs, were 
studied. The PDFs of the two VADs studied in the work of Chiu et al (2014) are reported in 
Fig.1, together with representative shear stress waveforms that were identified. The PDF is 
depicted as histogram bars in which the occurrences of SA along all the simulated particle 
trajectories are reported. 
The shear stress waveforms of the two VADs were characterized by the superimposition of 
stress peaks ranging from 60 to 250 Pa, for an overall duration of 10-20 ms (with durations of 
each peak varying from 3 to 6 ms). These data were the starting point for the design of the 
microfluidic platforms.  
 
FIG. 1 PDF of the SA of HeartAssist5 (a) and HeartMateII (b) VADs and representative shear stress waveforms 
extracted from the 90
th
 percentile of the PDFs. The histograms of PDF and shear stress waveforms were reproduced 
by data provided by (Chiu et al. 2014).  
2.1 Microfluidic model design 
2.1.1 Design of microfluidic stress-generating templates 
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          As a first step, a sample shear stress waveform with a triangular shape was considered, 
featuring a baseline shear stress value lower than 20 Pa, a peak shear stress of 130 Pa and 
duration of 4 ms. This sample waveform was chosen as a template pattern, characterized by 
typical values of shear stress and exposure time observed in MCS devices. The goal of this step 
was to test the feasibility of using microfluidic devices to replicate typical features of shear stress 
waveforms experienced by blood platelets in actual MCS devices. 
To this end, two microfluidic layout configurations were designed at different scale-sizes, 
corresponding to the opposing limits of attainable geometries with standard photo-lithography: a 
first configuration (M1) with a rectangular reference channel cross-section of 50 μm × 25 μm 
(width × height) and a second configuration (M2) with a reference channel cross-section of 500 
μm × 200 μm (width × height). As in most microfluidic applications, the heights of features in 
each configuration were maintained constant, achieving the desired levels of shear stress by 
either modulating the width of the channel (non-obstructive, NO, Fig. 2, top panel) or inserting 
obstacles along the channel (obstructive, O, Fig. 2, top panel). In both cases, the peak shear stress 
was obtained by decreasing the flow area with respect to the reference section of the channel. 
For the M1 configuration, the obstructive model (M1_O2) was obtained by inserting two 
oval-shape obstacles along the channel, while for the M2 configuration, either one and three 
obstacles were designed (obtaining M2_O1 and M2_O3 models). The dimensions of the 
obstacles were determined in order to obtain the same peak shear stress values as in the 
corresponding NO geometry, at the same flow rate. The dimensions of the designed models are 
summarized in Table 1. 
TABLE 1 Dimensions of the models designed in II.A.1: width (W) of the reference cross-section, height (h) and 
length (L) of the channel; width (Wfeat) and length (Lfeat) of the stress-generating features. Wfeat refers to the width of 
the narrowed section in NO models and to the width of each obstacle in O models 
 M1_NO M1_O2 M2_NO M2_O1 M2_O3 
N. of obstacles - 2 - 1 3 
W (μm) 50 50 500 500 500 
h (μm) 25 25 200 200 200 
L (mm) 2.1 2.9 17.1 20.7 15.3 
Wfeat (μm) 12 15 84 370 113 






2.1.2 Achieving different shear stress levels 
          As a second step of our approach, we tested how the levels and waveforms of shear stress 
in the microfluidic devices can be modulated, by varying the shapes and dimensions of the shear 
stress-generating features.  
To this end, a further NO model was designed, characterized by 3 different NO stress-generating 
features (M1_3SGF) as shown in Fig. 2, bottom panel: the NO feature described in the first 
designing step (subpanel i), an abrupt contraction followed by a sudden expansion (subpanel ii), 
and a smoothed narrowing feature without sharp corners (subpanel iii). The features were sized 
in order to generate shear stress peaks differing by three orders of magnitude (160, 80 and 1000 
Pa, respectively). 
 
FIG. 2 a) Example of non-obstructive (left) and obstructive (right) geometries. b) Geometries investigated in 2.1.2. 
Subpanels show the enlarged view of the three different kinds of narrowing: i) angled, ii) sharp and sudden, and iii) 
smoothed. The dimensions of the model in the figure are not reported in the actual scale in order to show the general 
pattern of the stress generating features. 
2.1.3 Design of microfluidic devices to replicate commercial VADs 
          Finally, we considered two commercial VADs: the HMII and the HA5 axial flow pumps. 
These devices have recently been studied through CFD analyses by Chiu and colleagues (Chiu et 
al 2014), who used a discrete phase model to extract shear stress waveforms along platelet 
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trajectories. Here, two microfluidic devices, termed the HMII_microfluidic and the 
HA5_microfluidic (Fig. 3), were designed in order to replicate the critical shear stress 
waveforms extracted by Chiu and colleagues (corresponding to the 90
th
 percentile of the stress 
accumulation distribution of each VAD). The original shear stress waveforms were described as 
a series of triangular shaped shear stress patterns that were replicated by a corresponding series 
of stress-generating features in the emulating microchannels. A reference channel cross-section 
of intermediate size (50 μm × 120 μm) and a NO configuration was chosen in both cases. 
 
FIG. 3 Microfluidic units emulating the shear stress waveforms corresponding to the 90th percentile of SA of HMII 
(a) and HA5 (b) VADs with enlarged views of the channel features. The dimensions of the model in the figure are 
not reported in the actual scale in order to show the general pattern of the stress generating features. 
2. 2 Computational Fluid Dynamic analyses 
The flow fields in all the described microdevices were analyzed through CFD using the 
commercial finite volume solver ANSYS Fluent
®
 (Ansys Inc., USA), following the approach 
proposed by Pelosi and co-authors (2014). NO models were discretized with hexaedral structured 
9 
 
grids, while obstructive models and M1_3SGF model were discretized with hexahedral 
unstrucured grids, due to the higher complexity of their fluid domains. The element size of each 
model was based on a previous sensitivity analysis in which the minimum number of elements in 
the channel cross-section required for convergence below 4% of the shear stress profile was 
determined. The sensitivity analysis lead to a minimum number of elements in the channel cross-
section of 15.  
The fluid phase, representing a solution of gel-filtered platelets (GFP) was modeled as an 
incompressible and Newtonian fluid with rheological properties of a serum-like medium: a 
density of 1000 kg/m3 and a dynamic viscosity of 0.001 Pa s. The choice of simulating GFP was 
adopted with the aim of replicating the currently used in vitro conditions tested in the HSD 
device for measuring shear-induced activation by means of the PAS assay. Indeed, in the present 
study the DTE approach was taken as a reference for the development of the microfluidic 
emulator devices. A SIMPLE method was used for pressure-velocity coupling and a second 
order upwind scheme was chosen for the discretization of the momentum equation. A constant 
uniform velocity and zero pressure were imposed as boundary conditions at the inlet and the 
outlet of the fluid domain, respectively. Velocities of 11.6 cm/s and 57 cm/s were assigned at the 
inlet of the M1 and M2 models, respectively, and a velocity of 10 cm/s was imposed in the two 
VAD emulating microchannels. In all the simulations the maximum Reynolds number was well 
below the limit of the transition flow regime. The lowest peak Reynolds number was 7 in model 
M1_NO, while the highest was close to 400 in model M2_NO. The peak Reynolds number refer 
to the values in the shear stress generating features where the velocities are higher than in the 
baseline part of the channels. 
The steady-state velocity and pressure fields were first computed through a steady flow 
simulation. Once convergence was reached, a transient simulation was run in which a discrete 
phase, modeled as buoyant spherical particles, was injected from a cross-section downstream of 
the inlet surface. The discrete phase was assigned characteristics of human platelets, with a 
diameter of 3 μm and the density of water, 998 Kg/m3. 
The particle tracking approach available in Fluent
®
 (Ansys Inc., USA) was used. According 
to this approach, the trajectories of a population of particles flowing in a fluid domain are 
computed by solving the momentum equation for the particle in a Lagrangian reference frame. 










where ?⃗?   and ?⃗? 𝑝 refer to the fluid and particle velocity, respectively; ρ and ρp to their density; 
and FD is a drag coefficient that depends on both the discrete and the continuous phase, and is 
expressed as 












and CD is a coefficient calculated according to the spherical drag law 







where a1, a2 and a3 are constant values that apply over several ranges of Rep (Morsi and 
Alexander 1972). 
In this work lift forces were not included in the equation of motion of the particles. This 
choice was made according to preliminary numerical simulations in which the contribution 
of lift forces was quantified and evaluated to be negligible in the models simulated in the 
present study. 
According to the discrete phase approach particles are not explicitly modeled within the 
discretized fluid domain of the continuous phase and the effect of the continuous phase on the 
particles is subsumed into drag force contributions. This approach is based on the assumption 
that the particulate phase is sufficiently diluted and occupies a small volume fraction (less than 
10%) of the fluid domain. In the present work, the dilution of platelets used in the DTE approach 
to quantify the shear-related platelet activation by means of the PAS assay was replicated. The 
PAS assay requires a concentration of the platelet sample of 20x10
3 platelets/μl, which 
corresponds to a volume fraction of 0.03%, supporting the use of the discrete phase approach in 
these models. Despite the approximation of neglecting the explicit presence of the particles in the 
discretized fluid domain, the discrete phase model allows to take into account the contribution of 
mass flow that the particles transfer to the continuous phase, through a fully-coupled approach. 
The fully-coupled approach is implemented in Fluent by adding a source of momentum to the 
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Navier-Stokes equation of the fluid which is proportional to the mass of particles entering a grid 
cell of the fluid domain and their velocity, as in the following equation: 
 𝐹𝑝 = ∑ [𝐹𝐷(𝑢𝑝𝑖 − 𝑢)]
𝑁𝑝
𝑖=1 ?̇?𝑝𝑖∆𝑡 (5) 
where Np is the number of particles entering the cell of the fluid domain, upi is the particle 
velocity, ?̇?𝑝𝑖 its mass flow rate and ∆𝑡 is the time step of the simulation. 
Particles were injected in the fluid domain according to the following seeding strategy: with the 
aim of obtaining probabilistic distribution of shear stress waveforms along platelet trajectories, a 
population of about 700 platelets was injected from a cross-section downstream of the inlet 
surface in each model. The injections were distributed in time in order to replicate a dilution of 
20x10
3
 platelets/μl. Moreover, the spatial distribution of platelets was assigned following the 
velocity distribution of the flow field on the injection surface in order to replicate the fact that 
trajectories characterized by higher velocities will be followed by a larger population of platelets. 
In the computational models particle-particle interactions were neglected since this 
approximation is justified by the condition of high dilution of the particulate phase already 
satisfied, while particle-wall interactions were treated as elastic collisions: a particle impacting 
the wall is reflected by retaining the same amount of normal and tangential momentum (with 
respect to the wall) before the impact. 
The discretization step for the advancement in time of the solution was set to 0.1 ms and for 
each model the simulation was run until all the particles escaped the fluid domain.  
At each time step, the stress tensor acting on a particle was assumed equal to the stress tensor 
in the fluid where the particle center of mass is located. In order to condense the complex stress 
tensor instantaneously associated to each particle in a scalar quantity, an effective measurement 
of shear stress was derived: as described in previous computational study (Apel et al 2001, 
Alemu and Bluestein 2007), the so-called scalar stress was computed from the fluid stress tensor 







2 − 𝜏11𝜏22 − 𝜏11𝜏33 − 𝜏22𝜏33 + 3(𝜏12
2 + 𝜏13
2 + 𝜏23
2 ) (5) 
Particle trajectories were extracted from the discrete phase simulations. Moreover, the scalar 
stress along each trajectory and at each time step was also exported: from each simulated model, 
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N dynamic scalar stress waveforms were obtained (where N is the number of simulated particles 
in the domain). The linear stress accumulation (SA) of each trajectory was computed as 




thus obtaining a stochastic distribution of  SA in each microfluidic model. Indeed, the probability 
density function (PDF) of SA can be seen as the synthetic description of its flow-related 
thrombogenic potential, and was used to identify representative shear stress waveforms of the 
microfluidic VAD emulator channels. 
The geometry of each model was designed according to preliminary analytical formulae and then 
optimized through the CFD analyses. A semi-automatic algorithm was implemented allowing to 
optimize channel geometrical parameters (widths and lengths of the shear stress-generating 
features) based on the discrepancy between descriptive parameters of the shear stress waveforms 
along platelet trajectories in the microfluidic channels and the reference shear stress waveform to 
be replicated. 
3. RESULTS 
3.1 Design of microfluidic stress-generating templates 
         In Fig. 4, the contours of the scalar stress in the mean longitudinal plane of the models 
designed in 2.1.1 are shown. The scalar stress levels in the stress generating features show a 
similar trend, even though differences were observed in terms of maximum scalar stress, as 
reported in Table 2 where the maximum scalar stress values and the pressure drop across the 
models are reported. Maximum values of scalar stress range from 305 (model M2_NO) to 332 Pa 
(model M1_O1).  
TABLE 2 Maximum scalar stress (σmax) values and pressure drop levels (∆P) in all the models simulated. 
 M1_NO M1_O2 M2_NO M2_O1 M2_O3 
σmax (Pa) 317 330 325 305 303 
∆P (atm) 0.24 0.90 0.29 0.70 1.1 
In general, higher pressure drops were observed in obstructive models independently of the 
maximum scalar stress reported. 
In M2 models, flow trails could be observed downstream of the stress-generating feature, unlike 
models M1_NO and M1_O2, where a symmetric stress distribution was obtained across the 
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stress-generating feature. The latter was characterized by predominant viscous flow and the 
narrowing of the channel did not lead to any flow disturbances. On the contrary, the flow regime 
was different for configuration M2_NO, where the flow rate was 300 fold higher than in 
M1_NO. 
 
FIG. 4 Contours of scalar stress in the mean longitudinal plane of the stress generating features in the models 
designed in 2.1.1. The models are not in their actual scale dimensions in order to allow comparison between 
different models. 
In order to compare results obtained from the particle tracking simulations, distributions of 
parameters extracted from platelet trajectories were compared. In all the models, the median 
value of the shear stress in the baseline part of the channel was below 10 Pa and no trajectories 
reported scalar stress values reaching 20 Pa, which is in agreement with the desired baseline 
values. In Table 3,the  distributions of peak scalar stress and exposure time along particle 






 percentile values. 
In general, symmetrical distributions were obtained in terms of scalar stress values which has 
lower and higher percentiles almost equidistant from the median value (50th percentile). On the 
contrary the distributions of exposure time along trajectories are non symmetrical with the 
median values located in the bottom part of the distribution and a long tail extending towards 
higher values. However, in all the models a large fraction of trajectories (70% of the total) falls 
in a range between 0.8 and 1.2 of the median values, which means that a large population of 










 percentile) and 90
th
 percentiles of σpeak and Tpeak along particle trajectories. 




of σpeak (Pa) 
54 65 55 61 54 
50
th
 percentile of 
σpeak (Pa) 
132 128 132 128 130 
90
th
 percentile of 
σpeak (Pa) 
215 236 204 238 214 
10
th
 percentile of 
Tpeak (ms) 
3.5 3.2 2.9 2.8 3.1 
50
th
 percentile of 
Tpeak (ms) 
4.2 4.0 4.1 4.0 3.9 
90
th
 percentile of 
Tpeak (ms) 
8.4 7.7 10 9.4 7.8 
For this reason, as a result of the design optimization phase, all the models were set to have 
the same median values of peak scalar stress and exposure time. In particular, the median values 
of the distributions were chosen as representative parameters to describe the shear stress patterns 
generated by the microchannels. From this point of view, the models replicated the template 
shear stress patterns chosen in the designing phase, with peak scalar stress and exposure time 
close to the objective values: the desired template shear stress waveform was then considered 
achieved in terms of representative statistical values of peak scalar stress (130 Pa) and duration 
(4 ms), suggesting the potential use of microfluidics in performing HSD-like shear-controlled 
experiments. Furthermore, the distributions of the shear stress waveform parameters showed 
similar trends demonstrating that similar shear stress patterns experienced by platelets can be 
replicated in different microfluidic devices. Although similar results were obtained with NO and 
O features in terms of generated shear stress waveforms, NO channels have the advantage – 
given the aspect ratios of obstacles considered here - of being easier to accurately fabricate 
through soft lithography. 
3. 2 Achieving different shear stress levels 
The maximum scalar stress levels in the three stress-generating features of M1_3SGF model 
were 317 Pa, 110 Pa, and 920 Pa, respectively, following the ranges set in the designing phase. 
This result demonstrated how it could be possible to span very large ranges of shear stress within 
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a single microfluidic device. A similar result could be observed from the transient discrete phase 
simulation. As an example, the scalar stress along a representative particle trajectory reporting 
median values of peak shear stresses is shown in Fig. 5. 
 
FIG. 5 Scalar stress along a particle flowing in M1_3SGF, corresponding to the 90th percentile of SA. 
3. 3 Microfluidic devices to replicate commercial VADs  
          As a third step, two microfluidic models (Fig. 3) were designed in order to replicate 
significant scalar stress trajectories computed in a previous study (Chiu et al 2014) for two 
commercial VADs: the HMII and the HA5 devices. In Fig. 6 the PDF of SA of the HMII and 
HA5 microfluidic channels are shown: as observed, in both the models the SA spans a wide 
range of values. However, the distribution is characterized by a long tail that extends towards 
higher values and the fraction of particles experiencing higher levels of SA (in the region above 
the 50
th
 percentile of the distribution) is more dispersed and non-uniform. For this reason the 
trajectories falling in this part of the distribution were considered to be less representative of the 
shear-induced thrombogenic potential of the microfluidic channel. On the contrary the region of 
the distribution ranging from the 10
th
 percentile to the median values is more uniform. Thus, in 
this work trajectories characterized by levels of SA values in this range of the PDF were 
identified as the representative trajectories of the microfluidic devices. Those representative 
trajectories are reported in Fig. 7 and compared to the VAD waveforms obtained at the 




FIG. 6 PDF of SA distribution obtained in the (a) HMII and (b) HA5 microfluidic models. 
Although schematic, the microfluidic platforms succeeded in capturing the main features of the 
scalar stress waveforms experienced by blood platelets at the macroscale, in terms of both peak 
of scalar stress values and exposure time. The pressure drop across the two channels was 4.9 atm 
and 2.3 atm in model HMII and HA5, respectively.  
 
FIG. 7 Comparison between the scalar stress waveforms corresponding to the 90th percentile of SA distribution 
obtained in the (a) HMII and (b) HA5 VAD simulations at the macroscale (Chiu et al. 2014) and in the 
corresponding microfluidic simulations. 
4. DISCUSSION 
In the present work, we demonstrate the feasibility of using PDMS microfluidic platforms to 
replicate VAD-specific shear stress history patterns The high resolution achievable with soft 
lithography allowed the design of microfluidic devices in which shear stress levels could be 
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finely controlled, thus representing the basis for a technique well-suited to design lab-on-chip 
shear-mediated platelet activity assays.   
      Recently, microfluidic devices have been developed to test platelet function under flow. 
Platelet adhesion on collagen-coated glass surfaces was investigated by detecting platelet 
cytosolic Ca
2+
 influx using fluorescence microscopy in microfluidic channels perfused at 
physiological arterial shear rate (Zijp et al, 2014). Similar studies were carried out by Gutierrez 
and colleagues (2008) who detected platelet adhesion to glass surfaces coated with extracellular 
matrix proteins under flow by labeling platelet dense granules with a fluorescence dye. Li and 
Diamond (2014) developed a microfluidic device allowing to test the effect of different anti-
platelet drugs on a single platform under physiological and constant venous shear rate, by 
monitoring the fluorescence intensity of platelets labeled with anti-human CD61 antibody. Li 
and co-authors (2012) proposed a microfluidic PDMS-based device to monitor platelet 
aggregation at different shear rates in microfluidic channels with a modeled stenosis. An optical 
system measuring the transmitted light across the channels was developed allowing monitoring 
of the formation of platelet thrombus inside the channels. In a more recent paper (Li et al. 2014), 
the same device was used to test the effect of anti-platelet drugs at different shear rates. These 
studies showed the potential use of microfluidics to test and investigate platelet behaviour under 
flow. However, the analyses were performed under constant shear rate. To the best of our 
knowledge, no previous studies in the literature made use of microfluidic technology to develop 
systems for testing platelets under dynamic and controlled shear stress patterns, demonstrated to 
have a strong influence in triggering platelet activation (Girdhar and Bluestein, 2008). 
       PDMS microfluidic platforms have significant advantages as they are transparent, gas 
permeable, chemically inert; the bulk material cost is low and fabrication may be carried out 
under normal laboratory conditions, without the need for expensive clean room facilities (Friend 
and Yeo 2010). PDMS-based microfluidic systems allow multiple experiments or tests to be 
performed in parallel on a small footprint. Furthermore, the high surface-to-volume ratio 
dramatically reduces reaction times and allows for very precise fluid handling. Nevertheless, in 
the design of microfluidic systems, some constraints inherent to soft lithographic techniques 
have to be considered. First, high resolution photomasks printed on low-cost transparencies 
allow for lateral resolutions up to 5 µm. Chrome masks are required beyond this limit, despite a 
price increase of several orders of magnitude. Second, the height of microfabricated features 
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(e.g. fluidic channels) is limited by the ability to uniformly deposit photoresist on silicon wafers. 
Spin coating yields thicknesses in the range 1-200 µm when using standard SU-8 resins, 
presenting limits on maximum dimensions of attainable features. Third, a maximum aspect ratio 
of silicon/photoresist master features is generally set to 20, although aspect ratios (ARs) larger 
than 50 can be achieved at the expense of process repeatability (Liu et al 2015). However, due to 
the low elastic modulus of PDMS, when features having AR higher than 10 or lower than 0.1 are 
realized, pairing and sagging effects can compromise the designed geometry (Xia and 
Whitesides 1998). Fourth, plasma sealing is watertight and irreversible, and can withstand, 
reasonably, hydraulic pressures as high as 5-10 atm, depending on the channel dimensions and 
the effective sealing area. 
 The use of microfluidics also allows for a high flexibility, as demonstrated by the 
simulation of M1_3SGF model. The designed microchannel is able to span several orders of 
magnitude of shear stress levels, up to values approaching 1000 Pa, which is not attainable with 
the traditional HSD. As reported, high pressure drop levels were obtained in the microfluidic 
emulator channels (HMII and HA5 microfluidic models). This would limit the possible number 
of repetitive units on a single platform to one or two elements on  single platforms, since the 
bonding between the PDMS and the glass slide would reasonably withstand maximum pressure 
head of about 5 atm. Proper experimental approaches should be adopted in order to increase the 
number of passages of the fluid sample through the microfluidic units, as for example a system 
of two synchronized syringe pumps allowing the sample to flow alternatively in the two 
directions. 
Despite the promising results, the modeling strategy that was adopted in this work has some 
limitations. In particular, an assumption was made in order to compute shear stresses acting on 
platelets that were assumed to be equal to the shear stress in the fluid field where the center of 
mass of each platelet is located. A more accurate description of shear stress on the platelet 
surface would require more sophisticated fluid-structure interaction approaches in which 
platelets would be explicitly modeled in the discretized fluid domain, resulting in the need for a 
refined fluid mesh around particles and leading to heavier computational models, especially in 
cases in which a large number of particles are modeled in relatively large fluid domains. This 
approach would not be suited to our models in which the platelet size (3 μm diameter) is much 
smaller than the channel dimensions which have lengths that vary from a minimum of 2 mm to a 
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maximum of 20 mm, approximately. In the last decades, the Lattice-Boltzmann method (LBM) 
has emerged as an alternative to standard CFD methods. According to the LBM the fluid is 
treated as a distribution of fictitious particles on a fixed regular grid which determines 
macroscopic properties of the flow field, while evolving over time through processes of 
streaming and collisions between particles (Chen et al. 1992). In general the LBM method 
performs better compared to standard CFD methods in terms of computational efficiency and 
scalability. In a recent work, the LBM has been used by Wu and colleagues (Wu et al. 2011) to 
compute platelet trajectories in microfluidic channels. Although the advantage of this method in 
providing a more accurate description of  the interaction between the continuous and discrete 
phases, this approach would still be too computationally expensive for our models where large 
number of particles are tracked. In fact, in the work published by Wu and collaborators, a total 
number of 40 particles was simulated in each model and furthermore, particles characterized by 
longer residence time were not included in order to limit the simulation duration. Based on these 
considerations, the discrete phase model implemented in Fluent has been considered more 
appropriate to the present study in which the aim is to implement a numerical approach that 
allows to describe on a statistical basis the behaviour of a representative population of platelets 
flowing in microfluidic channels. Moreover, the approach is intended to represent a designing 
tool to optimize the microfluidic channel design, thus requiring additional iterative runs to be 
accomplished. 
With the envisioned utilization of the PAS assay (Jesty and Bluestein 1999, Jesty et al 2003) 
to quantify shear-mediated platelet activation of the microchannel, the system must allow the 
collection of 10 μl of GFP. After a desired number of passages through the device, 10 μl of 
activated sample will be collected and assayed spectrophotometrically for generated thrombin 
using a thrombin-specific substrate, normalizing the results with respect to positive and blank 
control samples. From this perspective, the priming volume of the microchip should be increased 
by extending the connecting channels to the pumps in order to guarantee the collection of at least 
10 μl of fluid needed to perform a single PAS assay. Assuming a chip consisting of 1 single 
repetition of the HMII_microfluidic unit (characterized by a priming volume of about 62 nl), at a 
flow rate of 36 μl/min, around 17 s would be necessary to flow the 10 μl sample volume in one 
direction. In order to replicate 100 passages through the device, the test would take 
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approximately 30 min to be performed. A further decrease of testing time could be obtained by 
reducing the sample volume needed with an ad hoc modification of the standard PAS assay. 
The possibility of adopting strategies to enhance mixing of platelets must also be considered, 
as the low flow regime attainable in microfluidic systems strongly limits particles and species 
mixing. A contemplated approach might include the introduction of bas-relief structures on the 
top of the channel, as proposed by Stroock and co-authors (2002). Such structures generate local 
convective phenomena enhancing mixing of the fluid particulate sample, which would be of 
value to assure uniform activation levels over the population of platelets assayed. 
We have demonstrated the feasibility of downscaling HSD-like experiments on a 
microfluidic level. This study serves as a proof-of-concept and is intended to set the basis for the 
future development of a Lab-on-a-Chip system able to perform device-specific and patient-
specific platelet activity state assays. Validation of the microfluidic platforms through 
comparison with test-cases performed on standard laboratory systems (i.e. HSD) is currently 
ongoing.  
In order to develop a fully functional point-of-care (POC) device, some additional critical 
points need to be addressed. First, in this preliminary study GFP was simulated in the 
microfluidic channels. This choice was done with the aim of replicating the in vitro conditions 
tested in the HSD to quantify the shear-induced activation by means of the PAS assay. The 
possibility of using whole blood should also be considered since this would ultimately represent 
a more suitable approach for a POC device. However in case of whole blood the assumption of 
highly dilution of the particulate sample and of absence of particle interactions could not be fully 
satisfied and more sofisticated discrete phase models should be implemented in order to account 
for these effects. Second, issues arising from interfacing the microfluidic device to the patient 
must be considered. Filling of the chip with patient blood must be achieved in a manner that 
minimizes the air-blood interface, which could potentially affect platelet function. An ad hoc 
connection between the chip and the pumping system should be studied in order to minimize the 
dead volume of the assembled system. Finally, as highlighted, downscaling and on-chip 
integration of the assay for platelet activation quantification is vital to advance the system for 
POC diagnostic use. 
The approach that we described could be also applied to other clinical scenarios. As an 
example, the POC device could be designed to emulate hemodynamics in patient-specific disease 
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conditions. To this end, CFD analyses on patient-specific anatomies (e.g. aortic stenosis or 
obstructive coronary artery disease) could be utilized to design a “personalized” microfluidic 
platform for analysis of the efficacy of individual patients anti-thrombotic therapy, under the 
actual dynamic conditions of their own specific flow altering anatomy.  
5. CONCLUSIONS 
In the present study the use of microfluidic technologies to design platforms for shear-
controlled assays on blood under dynamic conditions has been studied through CFD analyses: a 
range of types and scale-sized microfluidic geometries were analyzed. Moreover, a CFD-based 
approach to design microfluidic platforms for emulation of the shear-induced thrombogenic 
potential of MCS devices has been presented. Test cases on two commercial VADs were 
investigated to demonstrate the feasibility of this approach. Research activities are now focusing 
on fabrication and experimental validation of microfluidic VAD-emulating prototypes. 
Development of an effective, accurate, personalized and user-friendly POC system will enhance 
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